v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (UNAUDITED) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Operating expenses        
Research and development $ 428,529 $ 688,041 $ 1,228,141 $ 1,009,026
General and administrative 792,129 1,082,846 2,203,725 2,276,928
Total operating expenses 1,220,658 1,770,887 3,431,866 3,285,954
Operating loss (1,220,658) (1,770,887) (3,431,866) (3,285,954)
Other expense (income)        
Change in fair value of derivative liabilities 26,353 (17,971,742) (9,550) (5,151,124)
Fair value of derivative liabilities in excess of proceeds 0 0 0 322,644
Interest expense 171,625 293,965 337,980 410,028
Total other expense (income), net 197,978 (17,677,777) 328,430 (4,418,452)
(Loss) income before income taxes (1,418,636) 15,906,890 (3,760,296) 1,132,498
Provision for income taxes 1,600 1,600 1,600 1,600
Net (loss) income and comprehensive (loss) income $ (1,420,236) $ 15,905,290 $ (3,761,896) $ 1,130,898
(Loss) earnings per common share:        
Basic (in dollars per share) $ (0.01) $ 0.12 $ (0.02) $ 0.01
Diluted (in dollars per share) $ (0.01) $ 0.08 $ (0.02) $ 0.01
Weighted average shares of common stock outstanding used to compute earnings per share:        
Basic (in shares) 183,052,175 132,923,037 182,654,571 132,826,677
Diluted (in shares) 183,052,175 189,094,958 182,654,571 172,058,053

Source